Absolute β-catenin concentrations in Wnt pathway-stimulated and non-stimulated cells

References

• Abraham SC, Wu TT, Hruban RH, Lee JH, Yeo CJ, Conlon K, Brennan M, Cameron JL, Klimstra DS. Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway. American Journal of Pathology 2002; 160: 953–962
   PubMed Web of Science ®Google Scholar
• Cheah PY, Choo PH, Yao J, Eu KW, Seow-Choen F. A survival-stratification model of human colorectal carcinomas with beta-catenin and p27kip1. Cancer 2002; 95: 2479–2486
   PubMed Web of Science ®Google Scholar
• Chu EY, Hens J, Andl T, Kairo A, Yamaguchi TP, Brisken C, Glick A, Wysolmerski JJ, Millar SE. Canonical WNT signaling promotes mammary placode development and is essential for initiation of mammary gland morphogenesis. Development 2004; 131: 4819–4829
   PubMed Web of Science ®Google Scholar
• Clements WM, Wang J, Sarnaik A, Kim OJ, MacDonald J, Fenoglio-Preiser C, Groden J, Lowy AM. beta-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer. Cancer Research 2002; 62: 3503–3506
   PubMed Web of Science ®Google Scholar
• Cui J, Zhou X, Liu Y, Tang Z, Romeih M. Wnt signaling in hepatocellular carcinoma: analysis of mutation and expression of beta-catenin, T-cell factor-4 and glycogen synthase kinase 3-beta genes. Journal of Gastroenterology and Hepatology 2003; 18: 280–287
   PubMed Web of Science ®Google Scholar
• De La CA, Romagnolo B, Billuart P, Renard CA, Buendia MA, Soubrane O, Fabre M, Chelly J, Beldjord C, Kahn A, Perret C. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proceedings of the National Academy of Sciences USA 1998; 95: 8847–8851
   PubMed Web of Science ®Google Scholar
• Doucas H, Garcea G, Neal CP, Manson MM, Berry DP. Changes in the Wnt signalling pathway in gastrointestinal cancers and their prognostic significance. European Journal of Cancer 2005; 41: 365–379
   PubMed Web of Science ®Google Scholar
• Fujimori M, Ikeda S, Shimizu Y, Okajima M, Asahara T. Accumulation of beta-catenin protein and mutations in exon 3 of beta-catenin gene in gastrointestinal carcinoid tumor. Cancer Research 2001; 61: 6656–6659
   PubMed Web of Science ®Google Scholar
• Hao X, Tomlinson I, Ilyas M, Palazzo JP, Talbot IC. Reciprocity between membranous and nuclear expression of beta-catenin in colorectal tumours. Virchows Archiv 1997; 431: 167–172
   PubMed Web of Science ®Google Scholar
• Kahmann S, Herter P, Kuhnen C, Muller KM, Muhr G, Martin D, Soddemann M, Muller O. A non-radioactive protein truncation test for the sensitive detection of all stop and frameshift mutations. Human Mutations 2002; 19: 165–172
   PubMed Web of Science ®Google Scholar
• Katoh M. Regulation of WNT3 and WNT3A mRNAs in human cancer cell lines NT2, MCF-7, and MKN45. International Journal of Oncology 2002; 20: 373–377
   PubMed Web of Science ®Google Scholar
• Kutzner N, Hoffmann I, Linke C, Thienel T, Grzegorczyk M, Urfer W, Martin D, Winde G, Traska T, Hohlbach G, et al. Non-invasive detection of colorectal tumours by the combined application of molecular diagnosis and the faecal occult blood test. Cancer Letters 2005; 229: 33–41
   PubMed Web of Science ®Google Scholar
• Lifschitz-Mercer B, Amitai R, Maymon BB, Shechtman L, Czernobilsky B, Leider-Trejo L, Ben Ze'ev A, Geiger B. Nuclear localization of beta-catenin and plakoglobin in primary and metastatic human colonic carcinomas, colonic adenomas, and normal colon. International Journal of Surgical Pathology 2001; 9: 273–279
   PubMed Web of Science ®Google Scholar
• Maruyama K, Ochiai A, Akimoto S, Nakamura S, Baba S, Moriya Y, Hirohashi S. Cytoplasmic beta-catenin accumulation as a predictor of hematogenous metastasis in human colorectal cancer. Oncology 2000; 59: 302–309
   PubMed Web of Science ®Google Scholar
• Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 1997; 275: 1787–1790
   PubMed Web of Science ®Google Scholar
• Nathke IS. The adenomatous polyposis coli protein: the Achilles heel of the gut epithelium. Annual Reviews in Cell Development Biology 2004; 20: 337–366
   PubMed Web of Science ®Google Scholar
• Pierceall WE, Woodard AS, Morrow JS, Rimm D, Fearon ER. Frequent alterations in E-cadherin and alpha- and beta-catenin expression in human breast cancer cell lines. Oncogene 1995; 11: 1319–1326
   PubMed Web of Science ®Google Scholar
• Shibamoto S, Higano K, Takada R, Ito F, Takeichi M, Takada S. Cytoskeletal reorganization by soluble Wnt-3a protein signalling. Genes Cells 1998; 3: 659–670
   PubMed Web of Science ®Google Scholar
• Smith KJ, Johnson KA, Bryan TM, Hill DE, Markowitz S, Willson JK, Paraskeva C, Petersen GM, Hamilton SR, Vogelstein B. The APC gene product in normal and tumor cells. Proceedings of the National Academy of Sciences USA 1993; 90: 2846–2850
   PubMed Web of Science ®Google Scholar
• Tickenbrock L, Kossmeier K, Rehmann H, Herrmann C, Muller O. Differences between the interaction of beta-catenin with non-phosphorylated and single-mimicked phosphorylated 20-amino acid residue repeats of the APC protein. Journal of Molecular Biology 2003; 327: 359–367
   PubMed Web of Science ®Google Scholar
• Ueda M, Gemmill RM, West J, Winn R, Sugita M, Tanaka N, Ueki M, Drabkin HA. Mutations of the beta- and gamma-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas. British Journal of Cancer 2001; 85: 64–68
   PubMed Web of Science ®Google Scholar
• Vainio SJ. Nephrogenesis regulated by Wnt signaling. Journal of Nephrology 2003; 16: 279–285
   PubMed Web of Science ®Google Scholar
• Woo DK, Kim HS, Lee HS, Kang YH, Yang HK, Kim WH. Altered expression and mutation of beta-catenin gene in gastric carcinomas and cell lines. International Journal of Cancer 2001; 95: 108–113
   PubMed Web of Science ®Google Scholar
• You L, He B, Xu Z, Uematsu K, Mazieres J, Mikami I, Reguart N, Moody TW, Kitajewski J, McCormick F, Jablons DM. Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells. Oncogene 2004; 23: 6170–6174
   PubMed Web of Science ®Google Scholar
• Zhang B, Ougolkov A, Yamashita K, Takahashi Y, Mai M, Minamoto T. beta-Catenin and ras oncogenes detect most human colorectal cancer. Clinical and Cancer Research 2003; 9: 3073–3079
   PubMed Web of Science ®Google Scholar